|Bid||0.0200 x 0|
|Ask||0.0250 x 0|
|Day's Range||0.0200 - 0.0250|
|52 Week Range||0.0200 - 0.0600|
|Beta (3Y Monthly)||1.68|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.27|
FSE: FKC), an advanced exploration and mining company focused on the production of graphite concentrate, is pleased to announce it has engaged NextCap Investor Relations LLC (“NextCap”) to lead a comprehensive, strategic investor relations and communications program in the United States and in other key regions. NextCap will partner closely with Focus Graphite’s Management Team and Board of Directors to develop and implement a comprehensive investor relations strategy with the purpose to increase the Company’s visibility in the investment community and goal to enhance shareholder value.
This week we saw the Focus Graphite Inc. (CVE:FMS) share price climb by 20%. But spare a thought for the long term...
OTTAWA, May 13, 2019 -- Focus Graphite Inc. (“Focus” or the "Company") (TSX-V: FMS; OTCQX: FCSMF; FSE: FKC), an advanced exploration and mining company focused on the.
OTTAWA, April 10, 2019 -- Focus Graphite Inc. (TSX-V:FMS) (“Focus” or the “Company”) is pleased to announce the appointment of Lindsay Weatherdon to the Board of Directors of.
OTTAWA, April 03, 2019 -- Focus Graphite Inc. (“Focus” or the "Company") (TSXV: FMS; OTCQX: FCSMF; FSE: FKC), an advanced exploration and mining company focused on the.
OTTAWA, March 19, 2019 -- Focus Graphite Inc. (TSX-V:FMS) (“Focus” or the “Company”) announces today that it has closed its previously announced equity financing (the.
FSE: FKC) (“Focus” or the “Company”) has announced today several changes to its Board of Directors. It is with great sadness that Focus announces that Chester Burtt has passed away. On behalf of its Board of Directors, management team and employees, Focus extends its deepest sympathies to Mr. Burtt’s family and thanks him for his dedication to the Company.
OTTAWA, Feb. 15, 2019 -- Focus Graphite Inc. is pleased to announce Grafoid’s worldwide launch of innovative suite of Oxidized Graphene products – GNOX™. The GNOX™ product.
OTTAWA, Feb. 13, 2019 -- Focus Graphite Inc. (TSX-V:FMS) (“Focus” or the “Company”) is pleased to announce it has secured an extension from the TSX Venture Exchange to complete.
Focus Graphite Inc. (TSX VENTURE:FMS) ("Focus" or the "Company") announces the closing of the first tranche of a non-brokered private placement (the "Offering") for gross proceeds of $650,000. The Company has issued 13,000,000 units (the "Units") at a price of $0.05 per Unit. Each Unit is comprised of one (1) flow-through common share and one common share purchase warrant (a "Warrant").
FSE: FKC) (“Focus” or the “Company”) is pleased to announce that its superfine, high-performance, conductive graphite used in the production of Lithium-Ion batteries is currently being tested by Major Battery Companies. Additionally, some battery technologies require that the graphite in use be almost 100% pure. Sources of pure, high-grade graphite are scarce and not readily available in consistent supply.
FSE: FKC) (“Focus” or the “Company”) is excited by the successful results of its efforts to advance the production of superfine, high-performance graphite using its proprietary processing technology. Already a source of high-grade graphite, suitable for use across a wide range of technology applications from energy storage to biomedicine, Focus Graphite is excited by the opportunity to expand its range of high-grade graphite. Over the last 4 years, Focus Graphite has embarked on an intensive value added product development and testing program.
FSE: FKC) (“Focus” or the “Company”) introduces its roadmap for refining BioMedical Grade Graphite to supply Grafoid’s product line of BioMedical Applications. Already an established source of high grade graphite, suitable for use in BioMedicine, Focus Graphite is also excited by the potential of its Rare Earth projects –such as the Kwyjibo Rare Earth Element (“REE”) Project (“Kwyjibo”) – which increases the range of materials that Focus may have the ability supply in the future. Within biomedicine, powerful imaging techniques from the single molecule to the whole organism directly impact the fundamental science or diagnosis.